OTCMKTS:BSPM

Biostar Pharmaceuticals (BSPM) Stock Price, News & Analysis

Biostar Pharmaceuticals logo

About Biostar Pharmaceuticals Stock (OTCMKTS:BSPM)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Biostar Pharmaceuticals, Inc. is a China-based pharmaceutical company engaged in the development, manufacture and sale of pharmaceutical products. The company serves the domestic Chinese healthcare market through its operations in Shaanxi Province.

Biostar’s product portfolio has historically included prescription and over-the-counter medicines, with products intended for areas such as respiratory health, inflammation and other common medical conditions. Its activities have included pharmaceutical research, production and commercialization through distribution channels serving hospitals, pharmacies and other healthcare providers.

The company is publicly traded on the OTC Markets under the symbol BSPM. Publicly available information about its current leadership, operations and product portfolio is limited, and specific product offerings and corporate activities may change over time.

AI Generated. May Contain Errors.

Receive BSPM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biostar Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BSPM Stock News Headlines

Beijing Biostar Pharmaceuticals Co. Ltd.
Beyond NVDA: The World’s Next #1 Company?
This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvidia's. A NASA scientist says the technology behind it is bigger than AI. Musk calls it "Amazing," and a Nobel Prize winner describes its power as "unprecedented in the history of life on Earth." Adam O'Dell, Chief Investment Strategist at Money and Markets, names the company at the center of it all.tc pixel
Biostar Pharmaceuticals Inc (BSPM)
Biostar Pharmaceuticals, Inc. (BSPM)
See More Headlines

BSPM Stock Analysis - Frequently Asked Questions

Biostar Pharmaceuticals, Inc. (OTCMKTS:BSPM) announced its quarterly earnings results on Wednesday, November, 15th. The company reported ($0.50) EPS for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biostar Pharmaceuticals investors own include Cellectar Biosciences (CLRB), Cyclacel Pharmaceuticals (CYCC), Gilead Sciences (GILD), MannKind (MNKD), MetaVia (MTVA), Rigel Pharmaceuticals (RIGL) and Sarepta Therapeutics (SRPT).

Company Calendar

Today
11/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:BSPM
CIK
N/A
Fax
N/A
Employees
200
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
87.14
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

This page (OTCMKTS:BSPM) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners